StockWatch
·
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Quarterly ResultOct 8, 2026, 07:46 AM

Hyperfine Reports Record Preliminary Q3 Revenue of $6.0M

AI Summary

Hyperfine, Inc. announced preliminary financial results for the third quarter ended September 30, 2026, reporting record revenue of approximately $6.0 million, a 53% sequential increase. The company also reaffirmed its full-year 2026 revenue outlook of $20 to $22 million. Notably, preliminary Q3 revenue exceeded net cash burn for the first time, with cash burn improving 29% sequentially to approximately $5.6 million. Estimated cash and cash equivalents stood at approximately $37.9 million as of quarter-end.

Key Highlights

  • Hyperfine reported preliminary Q3 2026 revenue of approximately $6.0 million, a 53% sequential increase.
  • Full year 2026 revenue outlook reaffirmed at $20 to $22 million.
  • Preliminary Q3 2026 net cash burn was approximately $5.6 million, a 29% sequential improvement.
  • Preliminary Q3 2026 revenue exceeded net cash burn for the first time.
  • Estimated cash and cash equivalents as of September 30, 2026, were approximately $37.9 million.
  • Nine months ended September 30, 2026, preliminary revenue was approximately $13.8 million.
  • Full year 2026 net cash burn guidance reaffirmed at $26 to $28 million.